Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244749 · ClinicalTrials.gov registry record
Role of Metabolic Enzymes in Non-Melanoma Skin Cancer
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 26
- Enrollment target
NCT02244749 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 26 participants.
The verdict
NCT02244749 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The researcher can proved that certain compounds play an important role in the prevention of skin cancer. Researcher can use specific compounds, which classified as metabolic enzymes, and lower concentrations and complete absent in skin cancer cells. Researcher can biopsies of normal skin and precancerous or cancerous lesions, and can compare the concentrations of these compounds to determine the difference between the two areas. The result can lead to further understanding of skin cancers and pre-cancers. Because skin cancers and pre-cancers are so common, any knowledge would be very useful for many people in the future and may be used for development of future treatments or prevention strategies.
Interventions
- OTHER skin specimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02244749
The ClinicalTrials.gov registry entry for NCT02244749 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which skin specimen is the first listed.
NCT02244749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02244749 about?
NCT02244749 is a clinical study titled "Role of Metabolic Enzymes in Non-Melanoma Skin Cancer". The researcher can proved that certain compounds play an important role in the prevention of skin cancer. Researcher can use specific compounds, which classified as metabolic enzymes, and lower concentrations and complete absent in skin cancer cells. Researcher can biopsies of normal skin and precan...
What is the current status of trial NCT02244749?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2011-03. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02244749?
The interventions under investigation include: skin specimen (OTHER).
Who is sponsoring clinical trial NCT02244749?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.